Temporal trends in prevention of venous thromboembolism following primary total hip or knee arthroplasty 1996-2001: findings from the Hip and Knee Registry
about
New insights into the mechanisms of action of aspirin and its use in the prevention and treatment of arterial and venous thromboembolismThe epidemiology of venous thromboembolismAspirin in the prevention and treatment of venous thromboembolismInsights into temporal patterns of hospital patient safety from routinely collected electronic dataCurrent issues in anticoagulation.Current concepts review: heparin-induced thrombocytopenia.Anticoagulation therapy with heparin and warfarin in total knee arthroplasty for osteoarthritis knee.Risk factors and distribution of symptomatic venous thromboembolism in total hip and knee replacements: prospective study.Cost effectiveness of venous thromboembolism pharmacological prophylaxis in total hip and knee replacement: a systematic review.Venous thromboembolism after total joint arthroplasty: results from a Japanese multicenter cohort study.Symptomatic venous thromboembolism and mortality in orthopaedic surgery - an observational study of 45 968 consecutive proceduresSimplifying thromboprophylaxis could improve outcomes in orthopaedic surgery.Is there adequate provision of venous thromboembolism prophylaxis following hip arthroplasty? An audit and international surveyCan Early Rehabilitation after Total Hip Arthroplasty Reduce Its Major Complications and Medical Expenses? Report from a Nationally Representative Cohort.Brief report: graduated compression stocking thromboprophylaxis for elderly inpatients: a propensity analysis.Comparison of Venous Thromboembolism after Total Artificial Joint Replacement between Musculoskeletal Tumors and Osteoarthritis of the Knee by a Single Surgeon.Epidemiology and risk factors for perioperative mortality after total hip and knee arthroplasty.Type of anaesthesia and the safety and efficacy of thromboprophylaxis with enoxaparin or dabigatran etexilate in major orthopaedic surgery: pooled analysis of three randomized controlled trials.Safety and efficacy of switching from low molecular weight heparin to dabigatran in patients undergoing elective total hip or knee replacement surgery.Postdischarge thromboprophylaxis and mortality risk after hip-or knee-replacement surgery.A 12 month review of a modified protocol using low dose Dabigatran Etexilate in postoperative thromboembolic prophylaxis in joint replacement surgery.Outpatient-based primary and secondary thromboprophylaxis with low-molecular-weight heparin.Transitions of care in anticoagulated patients.Ambulatory continuous posterior lumbar plexus nerve blocks after hip arthroplasty: a dual-center, randomized, triple-masked, placebo-controlled trial.Antithrombotic prophylaxis in major orthopaedic surgery: an historical overview and update of current recommendations.Review article: thromboprophylaxis after total hip replacement.Pharmacoeconomics of dabigatran etexilate for prevention of thromboembolism after joint replacement surgery.Economic impact of venous thromboembolism after hip and knee arthroplasty: potential impact of rivaroxaban.Preoperative versus postoperative initiation of thromboprophylaxis following major orthopedic surgery: safety and efficacy of postoperative administration supported by recent trials of new oral anticoagulantsRole of the pharmacist in achieving performance measures to improve the prevention and treatment of venous thromboembolism.A systematic review of contemporary trials of anticoagulants in orthopaedic thromboprophylaxis: suggestions for a radical reappraisal.Low incidence of symptomatic thromboembolic events after total ankle arthroplasty without routine use of chemoprophylaxis.Dabigatran etexilate for thromboprophylaxis in over 5000 hip or knee replacement patients in a real-world clinical setting.The influence of VKORC1 and CYP2C9 mutations on warfarin response after total hip and knee arthroplasty.Pulmonary embolism after IVC filter.Epidemiology of venous thromboembolism.Retrospective administrative database study of the time period of venous thromboembolism risk during and following hospitalization for major orthopedic or abdominal surgery in real-world US patients.Inpatient and outpatient occurrence of deep vein thrombosis and pulmonary embolism and thromboprophylaxis following selected at-risk surgeries.Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE-MODEL randomized trial.
P2860
Q26786574-6A58EC9D-64D5-412B-9E89-65E44AA0A2DBQ28067893-DBFF0D42-4CA6-466A-90A5-29E8CADAF326Q28199459-3B58586F-581F-4696-B88D-23CC2964365FQ28650512-D9141B4F-7368-42F3-8462-5209D38F8950Q33365707-70545619-4A29-4F71-8384-926C80948DCEQ33382108-7C8750C9-75F9-40AB-9724-88DAA34750FAQ33382823-B7C970BC-9253-43F6-9905-1788FE650B0FQ33399029-C54A8700-4B01-41F8-90A2-2CD004F34C42Q33605199-8069DBD3-F230-429B-9765-41A7C67A7146Q34468783-34EEBA6F-EA8E-489B-92BF-D24959B4D9FBQ34756347-04C89516-5E38-4531-96D9-056B1F4DB872Q35536242-308D1C4A-2B0D-421B-970D-55ACFC81570FQ35588756-3C0805FC-795A-4486-BAE4-DB1443BD91C1Q35753093-689555C6-76F0-46F0-9ECB-532DFA6D410CQ35901673-0A9EF1C3-4C77-4DE1-9A4C-0F2FBFD23164Q36063263-2DA39704-44E8-4245-B83A-5B780C367775Q36124047-06115E4A-116C-4F85-BAA2-8D2279A2AA5EQ36240036-8109694A-7A86-4262-A93F-C6FBEBF4A417Q36321989-CB7EA4DE-3071-4A04-BA2B-78B55FF19AD3Q36676398-B1AD32CB-3EBE-4DA7-93C3-5C6F925C22AAQ36688609-31C3B7B3-C7A0-46CF-8AD0-E47C2906D5CAQ36951531-6D7ABFF5-1B7A-4FFA-81D9-AAE0216930F6Q36957947-639E2562-EF48-4843-8496-74D24E8859A6Q36990020-25A9CEC0-2301-4124-9E48-9D825D848AA9Q37472172-DC945971-C4AF-48F8-9101-348B8BCC3738Q37739087-2DE1A54C-1253-428D-9A34-E967290AF410Q37847150-3D7259DB-EEA7-43A5-B831-B21AC2ACCC1AQ37889269-8FFE45A0-5537-41F5-8D81-10B1B41D80F2Q37956637-333CAB7A-D07A-4204-9018-D7D07CF2F724Q38095824-D0005B82-41FE-4720-A5AC-193CD59D5735Q38268898-DD692A8C-6D76-4F72-B9E1-A817384EFDF2Q38364878-534B4106-BAAE-4C77-A78B-AF89D7FA724EQ38394086-5DD53AFE-FDBD-4985-8C6F-87A961DE2682Q39124661-776F7878-3CBA-4D3B-BB63-FF75203D306AQ39858681-E93AAC5E-8996-4B8B-975F-71C2A9E31698Q41667853-82D55BCF-AE61-4BD0-AF29-2CE49747602DQ44132240-0368CB35-BB40-4090-8353-53AE87DB62DFQ46801023-7962CBD5-59B4-4FDC-97CD-08BB583F8509Q55044458-86CAEA60-44CB-419A-8374-6ADC30B057FE
P2860
Temporal trends in prevention of venous thromboembolism following primary total hip or knee arthroplasty 1996-2001: findings from the Hip and Knee Registry
description
2003 nî lūn-bûn
@nan
2003 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Temporal trends in prevention ...... from the Hip and Knee Registry
@ast
Temporal trends in prevention ...... from the Hip and Knee Registry
@en
Temporal trends in prevention ...... from the Hip and Knee Registry
@nl
type
label
Temporal trends in prevention ...... from the Hip and Knee Registry
@ast
Temporal trends in prevention ...... from the Hip and Knee Registry
@en
Temporal trends in prevention ...... from the Hip and Knee Registry
@nl
prefLabel
Temporal trends in prevention ...... from the Hip and Knee Registry
@ast
Temporal trends in prevention ...... from the Hip and Knee Registry
@en
Temporal trends in prevention ...... from the Hip and Knee Registry
@nl
P2093
P3181
P1433
P1476
Temporal trends in prevention ...... from the Hip and Knee Registry
@en
P2093
Frederick A Anderson
Jack Hirsh
Kami White
Robert H Fitzgerald
P304
P3181
P356
10.1378/CHEST.124.6_SUPPL.349S
P407
P433
P577
2003-12-01T00:00:00Z